التفاصيل البيبلوغرافية
| العنوان: |
Phase 1 trial of navitoclax and sorafenib in patients with relapsed or refractory solid tumors with hepatocellular carcinoma expansion cohort |
| المؤلفون: |
Emiloju, Oluwadunni E., Yin, Jun, Koubek, Emily, Reid, Joel M., Borad, Mitesh J., Lou, Yanyan, Seetharam, Mahesh, Edelman, Martin J., Sausville, Edward A., Jiang, Yixing, Kaseb, Ahmed O., Posey, James A., Davis, Sarah L., Gores, Gregory J., Roberts, Lewis R., Takebe, Naoko, Schwartz, Gary K., Hendrickson, Andrea E. Wahner, Kaufmann, Scott H., Adjei, Alex A., Hubbard, Joleen M., Costello, Brian A. |
| المساهمون: |
National Cancer Institute |
| المصدر: |
Investigational New Drugs ; ISSN 0167-6997 1573-0646 |
| بيانات النشر: |
Springer Science and Business Media LLC |
| سنة النشر: |
2024 |
| مصطلحات موضوعية: |
Pharmacology (medical), Pharmacology, Oncology |
| نوع الوثيقة: |
article in journal/newspaper |
| اللغة: |
English |
| DOI: |
10.1007/s10637-024-01420-8 |
| DOI: |
10.1007/s10637-024-01420-8.pdf |
| DOI: |
10.1007/s10637-024-01420-8/fulltext.html |
| الإتاحة: |
https://doi.org/10.1007/s10637-024-01420-8Test |
| حقوق: |
https://www.springernature.com/gp/researchers/text-and-data-miningTest ; https://www.springernature.com/gp/researchers/text-and-data-miningTest |
| رقم الانضمام: |
edsbas.1816AE7 |
| قاعدة البيانات: |
BASE |
